Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
about
Involvement of BDNF in age-dependent alterations in the hippocampusPhosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical ImplicationsPotential therapeutic effects of neurotrophins for acute and chronic neurological diseasesTranslating neurobehavioural endpoints of developmental neurotoxicity tests into in vitro assays and readoutsSynuclein impairs trafficking and signaling of BDNF in a mouse model of Parkinson's disease.The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.Adolescent social isolation influences cognitive function in adult rats.Can cinnamon bring aroma in Parkinson's disease treatment?Roles of Rheb(S16H) in substantia nigra pars compacta dopaminergic neurons in vivoMPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway.Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson's disease.BDNF Val66Met and spontaneous dyskinesias in non-clinical psychosis.Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease.The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's DiseaseNeurotrophin signalling: novel insights into mechanisms and pathophysiology.Pharmacological therapy in Parkinson's disease: focus on neuroprotection.Use of growth factors for the treatment of Parkinson's disease.Long noncoding nature brain-derived neurotrophic factor antisense is associated with poor prognosis and functional regulation in non-small cell lung caner.Consequences of brain-derived neurotrophic factor withdrawal in CNS neurons and implications in disease.Pharmacomodulation of microRNA Expression in Neurocognitive Diseases: Obstacles and Future Opportunities.Induction of GDNF and BDNF by hRheb(S16H) transduction of SNpc neurons: neuroprotective mechanisms of hRheb(S16H) in a model of Parkinson's disease.Integral Characterization of Defective BDNF/TrkB Signalling in Neurological and Psychiatric Disorders Leads the Way to New Therapies.Attenuation of MPTP neurotoxicity by rolipram, a specific inhibitor of phosphodiesterase IV.Neuroprotection by Exendin-4 Is GLP-1 Receptor Specific but DA D3 Receptor Dependent, Causing Altered BrdU Incorporation in Subventricular Zone and Substantia Nigra.Up-regulation of neurotrophic factors by cinnamon and its metabolite sodium benzoate: therapeutic implications for neurodegenerative disorders.An NR2B-Dependent Decrease in the Expression of trkB Receptors Precedes the Disappearance of Dopaminergic Cells in Substantia Nigra in a Rat Model of Presymptomatic Parkinson's Disease.An experimental study on intracerebroventricular transplantation of human amniotic epithelial cells in a rat model of Parkinson's disease.Elevated P75NTR expression causes death of engrailed-deficient midbrain dopaminergic neurons by Erk1/2 suppression.Brain-derived neurotrophic factor stimulates proliferation and differentiation of neural stem cells, possibly by triggering the Wnt/β-catenin signaling pathway.Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function.Individual Amino Acid Supplementation Can Improve Energy Metabolism and Decrease ROS Production in Neuronal Cells Overexpressing Alpha-Synuclein.Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease.Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration.Progesterone treatment decreases traumatic brain injury induced anxiety and is correlated with increased serum IGF-1 levels; prefrontal cortex, amygdala, hippocampus neuron density; and reduced serum corticosterone levels in immature rats.Zonisamide reduces nigrostriatal dopaminergic neurodegeneration in a mouse genetic model of Parkinson's disease.Ablation of serum response factor in dopaminergic neurons exacerbates susceptibility towards MPTP-induced oxidative stress.Inhibition of NMDA Receptors Prevents the Loss of BDNF Function Induced by Amyloid β.Gene Therapy for Parkinson's Disease, An Update.
P2860
Q21131072-85843A80-537D-4994-8AB9-AF366F3C97ADQ26753116-02DB3F36-31CB-42ED-96D1-ED13BDF33ED6Q26827281-749FA330-591E-45C0-B6F7-3ACE38E6A783Q28397001-214C8584-4831-442D-B86E-8A685201CD04Q33819127-066EE020-E4CC-46CC-8E99-AFE37E56A898Q33896035-62B7CC1C-F3D6-4F8A-8C70-F428409FCC8FQ34094455-1E5E77F9-C085-4BD6-8D3D-A86B4F9747F2Q35169915-12CD3635-C8A4-4987-825C-954917136BD7Q35180062-1F85F6B1-20AE-4022-8149-A7976552DCBDQ35484424-A41BBA41-0D92-4521-95D5-2A514301FB88Q35878528-D336D259-4AC6-4326-BD5B-B8423008C866Q36177241-2BBA4A06-5BEC-4419-95EE-10BE63CCD8E2Q36364388-C45C96CB-73FB-4C1B-A1A7-7132C865D184Q36494212-2B79ADDB-D2B4-4B4C-8A37-68819876F23CQ37629100-5E147F64-7A8B-4A73-B41F-972E41FBDDB7Q37741285-CC06755E-500D-4389-BE74-BB36988D09CAQ37762259-EFEE8EC6-919C-4BD6-B600-D1A9DBD94689Q38705376-AAA8404E-EB1F-4A2E-ACC8-D3BCC7781159Q38789148-00A97DD6-C4BC-4C13-9686-4B4F0C6C1111Q38843518-C426F68C-5234-41C2-B8C4-A70F8F003EE2Q38991795-8356207B-FF8D-4EDE-BCAA-55483430A515Q39109344-2751DB25-6FBD-4611-BA1D-9DA01FB1DF3DQ40517673-EC250917-E63D-4B8C-A096-4A0F5992967BQ40597127-ECEFFBB1-6818-4221-99EB-1CDB1DD382A1Q41035591-B34DB1ED-C2E1-4DA5-AB9B-DFD5C58AB5E2Q42204950-29168098-9AD8-4684-847D-C18BC544BD36Q43059942-40E88D67-F284-4A92-B123-C581D9DE5DAAQ43147443-A4DDA13B-18EF-490F-A2A7-412C9E5E9F5FQ44195362-656557D8-251C-4E1C-902F-A4D354C71ACEQ45300839-26D583D9-4F14-4235-9EF8-979B88018C34Q46349223-80877209-3CF7-4C1A-A259-C5DA30E15617Q47121220-91C78ED5-1A91-481F-B2CC-96202FC8AE26Q48046381-5D994FFA-8D0D-4759-8208-9593C147B827Q48130908-AD77D1DF-11D3-463C-BF99-A45F50E89D03Q48238293-A304E0EC-C9E0-416C-9FE9-BAA0993C0A16Q48647730-70616746-8E32-423D-B592-309395408953Q52691877-FDFAF8BD-1A8F-42E6-832D-D9125CA5D2E3Q55418920-6366D48B-EFC0-4D62-B893-DD89A8189C99
P2860
Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Inhibiting BDNF expression by ...... f nigral dopaminergic neurons.
@en
type
label
Inhibiting BDNF expression by ...... f nigral dopaminergic neurons.
@en
prefLabel
Inhibiting BDNF expression by ...... f nigral dopaminergic neurons.
@en
P2093
P1476
Inhibiting BDNF expression by ...... f nigral dopaminergic neurons.
@en
P2093
Batchelor PE
Howells DW
Porritt MJ
P304
P356
10.1016/J.EXPNEUROL.2004.11.030
P407
P577
2005-03-01T00:00:00Z